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Abstract
Background: Follow-up of abnormal outpatient laboratory test results is a major patient safety
concern. Electronic medical records can potentially address this concern through automated
notification. We examined whether automated notifications of abnormal laboratory results (alerts)
in an integrated electronic medical record resulted in timely follow-up actions.
Methods: We studied four alerts: hemoglobin A1c (HbA1c) ≥15%, positive hepatitis C antibody
(HCV), prostate specific antigen (PSA) ≥15 ng/mL, and thyroid stimulating hormone (TSH) ≥ 15
mIU/L. An alert tracking system determined whether the alert was acknowledged (i.e. provider
clicked on and opened the message) within two weeks of transmission; acknowledged alerts were
considered read. Within 30 days of result transmission, record review and provider contact
determined follow-up actions (e.g. patient contact, treatment etc.). Multivariable logistic regression
models analyzed predictors for lack of timely follow-up.
Results: Between May 2008 and December 2008, 78,158 tests (HbA1c, HCV, TSH and PSA) were
performed, of which 1163 (1.48%) were transmitted as alerts; 10.2% of these (119/1163) were
unacknowledged. Timely follow-up was lacking in 79 (6.8%) and was statistically not different for
acknowledged and unacknowledged alerts (6.4% vs. 10.1%; p =.13). Two-hundred two alerts (17.4%
of 1163) arose from unnecessarily ordered (redundant) tests. Alerts for a new versus known diagnosis
were more likely to lack timely follow-up (OR: 7.35; 95% CI: 4.16-12.97) whereas alerts related to
redundant tests were less likely to lack timely follow-up (OR: 0.24; 95% CI: 0.07-0.84).
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Conclusions: Safety concerns related to timely patient follow-up remain despite automated
notification of non-life threatening abnormal laboratory results in the outpatient setting.
Keywords
diagnostic errors; abnormal diagnostic test results; electronic medical records; patient follow-up;
patient safety; health information technology; communication; primary care
BACKGROUND
Outpatient care is often busy and fragmented, and therefore follow-up of abnormal laboratory
test results is prone to error. 1-10 Moreover, many laboratory test results in the outpatient setting
may not be immediately life threatening and hence not verbally reported to the ordering
provider. Therefore, missed laboratory results or delayed recognition of results leads to a
significant potential for outpatient diagnostic errors, adverse events and liability claims.4;9;
11-17
Most paper-based methods of communication between laboratories and ordering physicians
are especially vulnerable to failures. Automated systems notifying providers about abnormal
test results in integrated electronic medical record systems offer a potential solution.18 These
systems usually communicate through “alerts” (computerized notifications of abnormal
clinical information) transmitted directly to the provider's desktop, facilitating a rapid review
of patient information.15 The integrated electronic medical record used at all Veterans Affairs
(VA) facilities [the Computerized Patient Record System (CPRS)] uses the View Alert system
for automated notification of abnormal laboratory test results.
Abnormal result follow-up, however, will occur only if electronic communication of test results
(either through alerts or direct access of test result) is reviewed and acted upon by providers.
In previous work, we found abnormal diagnostic imaging alerts may not always be reviewed
by ordering practitioners, and practitioners who review them may not always act upon the
transmitted results in a timely manner.19 We thus hypothesized that a similar phenomenon
would exist for abnormal laboratory results. In this study we evaluated follow-up actions on
abnormal diagnostic laboratory tests transmitted as high-priority automated notifications to
ordering providers in an integrated electronic medical record. We also determined predictors
of lack of timely follow-up of these tests.
METHODS
The study was conducted in a large multispecialty ambulatory clinic of the Michael E. DeBakey
Veterans Affairs Medical Center (MEDVAMC) and its five satellite clinics located in
Southeast Texas from May 2008 to December 2008. To reliably assess follow-up actions on
outpatient test alerts, we only focused on abnormal tests that generated a “high-priority”
mandatory automated notification to a specified ordering provider without a concomitant
verbal notification. Hence we excluded abnormal tests which:
1) would be potentially life-threatening and hence meet our institution's criteria for verbal
notification or would result in immediate hospitalization at certain values (e.g., high
potassium values) or
2) were not ordered through computerized provider order entry and hence ordering
provider was not consistently specified or
3) did not generate mandatory alerts i.e,. the provider had an option to turn off the
notification for a specified level of abnormality.
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Four tests met our inclusion criteria: hemoglobin A1c (HbA1c) at a level ≥15%, positive
hepatitis C antibody (HCV), prostate specific antigen (PSA) at a level ≥15 ng/mL, and thyroid
stimulating hormone (TSH) at a level ≥ 15mIU/L.
Data Collection
While some site specific configurations exist, many automated notification processes in CPRS
are similar within the VA system. All VA health care providers receive important clinical
information in a “View Alert” window of the electronic medical record screen and life-
threatening findings are communicated by telephone. As their only “inbox” for all types of
CPRS notifications, providers are very dependent on the View Alert system. Providers see all
of their alerts when they first log on and again when they switch between patient records. New
alerts remain active in the window for two weeks unless acknowledged, after which they
disappear. Providers are expected to click on and open the alert to review the report (considered
acknowledged), after which the alert disappears from the window. The provider also may
become aware of an abnormal result without clicking on the alert if they were reviewing the
medical record for other purposes, hence directly accessing the result. Primary care providers
assign surrogate covering providers to receive their alerts when they are out of office.
On a daily basis we queried an Alert Tracking File of the electronic medical record to identify
outpatient alerts transmitted two weeks earlier. We tracked acknowledgement status of alerts
and extracted additional information such as patient identifiers, names of providers to whom
the alert was sent, the date and type of laboratory study. Within a week of data query, a reviewer
blinded to acknowledgement status evaluated the medical record using a standardized pre-
tested data collection instrument to determine any follow-up actions such as ordering a follow-
up test or referral, prescribing or changing treatment, contacting the patient, or patient refusal
of additional work-up. Based upon our pilot work, we unexpectedly found a fair number of
abnormal tests that were clinically determined to be unnecessary. For instance, we found some
tests to be redundant based on the frequency of being ordered i.e., ordered too soon after a
previous test or, in cases of hepatitis C, the ELISA was repeated unnecessarily despite a
previous positive value. We used objective pre-defined explicit criteria to determine
redundancy of tests (criteria specified in Table 3).20
In cases of no documented follow-up, a second study investigator evaluated the medical record
to confirm the findings and contacted the provider by telephone to obtain any additional
evidence of undocumented follow-up or a decision to not pursue follow-up. If we could not
contact any of the patient's providers or if the provider offered no additional information about
follow-up, we considered the alert to lack timely follow-up. This determination was made
approximately 30 days after alert transmission. In certain cases, we determined calling the
provider would be unnecessary or make no impact on outcome either because the alert offered
no new information over what was previously documented, the patient was already receiving
appropriate care for the condition, or the patient had died. These were considered as timely
follow-up; however, categorized as “no-impact”. Not all redundant tests were automatically
considered to be of no impact. For example, a redundant positive HCV would still need follow-
up if there was none documented for either the new or the previously positive test. Hence,
follow-up actions on a redundant test did not make it any less redundant.
Data analysis
In addition to descriptive data, we identified two groups of alerts corresponding to the two
outcome variables in our study: 1) alerts lacking electronic acknowledgment versus
acknowledged alerts; 2) alerts lacking timely follow-up versus those receiving timely follow-
up. We compared the distribution (as proportions) of several independent variables within each
group including: ordering provider specialty (primary care, medicine subspecialties, surgery
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etc.), ordering provider type (physician, trainee, and allied health professionals), redundant
tests and alerts signifying a new versus known diagnosis. To assess significance, chi-square
test was used for categorical variables and Fisher's exact test was used when chi-square
assumptions were not met. Hierarchical multivariable logistic regression models accounting
for clustering of laboratory tests by providers were used to identify factors associated with the
outcome variables, lack of acknowledgment and lack of timely follow-up. Covariates with p
values <0.2 in univariate testing were tested as predictor variables. For multivariable testing,
we combined specialties from univariate analysis into three groups: primary care, specialty
care and mental health care. The models were fit using maximum likelihood estimation and
odds ratios (OR) and 95% confidence intervals (CI) were calculated. We also described the
frequencies and types of redundant test alerts.
RESULTS
Between May 2008 and December 2008, 27,092 HbA1c, 22,837 PSA, 6271 HCV and 21,958
TSH tests were performed. A total of 1163 (1.49%) results were electronically transmitted as
mandatory high-priority alerts (including 29 HbA1c ≥15%, 448 PSA ≥15 ng/mL, 433 positive
HCV, and 253 TSH ≥15 mIU/L.). Acknowledged alerts constituted 89.8% of the total high-
priority alerts (1163). Figure 1 illustrates the outcomes of these 1163 alerts. No evidence of
documented follow-up action was found in 307 (26.4%) of the alerts, however 213 (18.3% of
1163) cases were categorized as no-impact alerts. In the remaining 94 cases, we called providers
to determine if for some reason follow-up had occurred but was not documented or if they had
additional knowledge that would affect outcome including patient or provider decision not to
pursue follow-up. Of these, 79 alerts (6.8% of total) were determined to lack timely follow-
up. Two-hundred two alerts (17.4% of 1163) were considered redundant of which 159 were
considered redundant based on repetition (recent or previous test).
Lack of Acknowledgement
Table 1 shows the distribution of the four laboratory tests between the acknowledged and
unacknowledged groups. We also show a comparison of several independent variables between
the two groups using univariate testing. Ordering provider type and specialty were significantly
different across the two groups. Trainees were less likely to acknowledge alerts compared to
attending/staff physicians and allied health providers (physician assistants and nurse
practitioners) whereas specialty services (including mental health) were less likely to
acknowledge alerts compared to primary care providers (p<.0001 for both). In a nested logistic
regression model (data not shown in Table 1), the following variables were significantly
associated with lack of acknowledgment of the alert, compared to attending physicians: allied
health care providers as ordering providers (OR, 4.32; 95% CI: 1.21-15.52) and trainees as
ordering providers (OR, 8.39, 95% CI: 2.97-23.68).
Lack of Timely Follow-up
Table 2 shows the distribution of the four laboratory tests between the timely follow-up versus
lack of timely follow-up groups. We show results of a univariate analysis comparing the several
independent variables between the 79 alerts determined to lack timely follow-up versus 1084
that received timely follow-up: Statistically, there was no significant difference in rates of lack
of timely follow-up between acknowledged and unacknowledged laboratory alerts (6.4% vs.
10.1%; p=.13). There was no significant difference in provider type but specialty differences
were significant. Redundant tests were more likely to receive follow-up (p<.01). Alerts for
conditions signifying new diagnoses were more likely to lack timely follow-up than alerts for
pre-existing conditions (p<.0001).
Singh et al. Page 4
Am J Med. Author manuscript; available in PMC 2011 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
In a nested logistic regression model the following were significantly associated with lack of
timely follow-up (data not shown in Table 2): redundant tests (OR: 0.24; 95% CI: 0.074-0.84)
with appropriately ordered tests as referent; alerts for conditions newly diagnosed i.e.,
diagnosis was not made until the lab was done (OR: 7.35; 95% CI: 4.16-12.97) with previously
known diagnosis as referent and mental health as a specialty (OR: 2.82; 95% CI: 1.06-7.54)
with primary care as referent.
Alerts Related to Redundant Tests
In Table 3 we list criteria to determine if an alert was related to a redundant laboratory tests
and their respective frequencies (total n=202). Because the VA's electronic medical record has
a reminder system that prompts the ordering provider about recent orders of the same test, we
further evaluated the subcategory of 159 alerts deemed redundant based on repetition. Overall,
we found 28 cases where the provider ordered the test too soon after the last PSA, TSH or
HbA1c and in 131 cases a second HCV ELISA test was ordered despite the presence of a
previous positive test. In our institution the reminder is set to prompt the ordering provider
about repetition when the new test is being ordered within 60 days from last TSH or PSA order
or within 90 days from last HCV or HbA1c order. However, in only 11 (7%) of these 159 cases
would the provider have received a computerized reminder prompting them of potential
redundancy based on repetition.
DISCUSSION
We tested whether certain abnormal outpatient laboratory tests were followed-up in a timely
manner in a multi-specialty clinic that used an integrated electronic medical record for
automated notification. We found 6.8% of alerts lacked follow-up at 30 days, suggesting that
follow-up of abnormal outpatient test results is not fail-safe even when providers are alerted
about abnormal results through the electronic medical record. Of concern was the finding that
there was lack of timely follow-up even when providers acknowledged notifications through
the electronic medical record, which was comparable to when they did not acknowledge them.
These findings are similar to our previous findings of follow-up on abnormal imaging alerts
in the same electronic medical record suggesting that this phenomenon may exist for all alerts
of abnormal diagnostic test results. Unexpectedly, we found 17% of abnormal test alerts were
related to tests that we deemed redundant based on pre-determined criteria. Alerts related to
these tests were less likely to lack timely follow-up.
Our findings have several significant implications for electronic medical record use in the
future. One, it cannot be assumed that automated notification of abnormal lab results within
an electronic medical record and the resultant acknowledgement will translate into timely
actions to address these alerts. Two, notifications of abnormal redundant tests appear to be a
distracting influence on providers who are missing essential alerts for newly diagnosed
conditions. Three, high-reliability tracking systems to monitor potential patient harm and
outcomes are needed, which also should account for follow-up actions by providers. Currently,
the only way to track follow-up actions on abnormal alerts is through medical record review,
a time-consuming and expensive procedure. However, individual-level tracking of follow-up
actions taken in response to abnormal test result notifications could be designed within the
electronic medical record. Thus, when providers process an alert, they could be provided order
sets of appropriate follow-up actions in a separate “pop-up” window (such as having a nurse
call the patient, setting up a return appointment, ordering a consultation or follow-up test, or
an option indicating no further action is required such as when a patient is already in hospice
care). These actions could be tracked through the electronic medical record and a reporting
process could be created for clinic administrators to review and identify patients who may have
truly “slipped through the cracks” without performing extensive record reviews. For instance,
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in cases of inaction on an abnormal lab at 2 weeks, the ordering provider or their surrogates
could be informed.
We previously determined rate of lack of timely follow-up for abnormal imaging alerts in the
same system and setting and found comparable results. Future work needs to confirm the extent
to which these findings exist in other electronic medical record systems. Because there could
be many potential reasons why busy providers in the front lines of health care delivery miss
abnormal test results, a multidisciplinary approach is needed to address test result follow-up
in future. For instance, an approach involving human computer interaction and informatics3;
21 that accounts for issues related to usability, organizational characteristics, technology, work-
flow and provider factors could be useful to explain why providers are unable to follow-up
results despite reading them and hence improve safety in this area. 22;23
Computerized reminders have been shown to reduce redundant tests in the inpatient setting.
24 However, our computerized reminder system would have prompted the ordering provider
only 7% of the time. Notably, in 131 cases where a positive Hepatitis C test previously existed
in the electronic medical record, the reminder logic was not set to prompt providers that they
were ordering a repeat, redundant test. Current computerized reminder systems could be better
designed to reduce test redundancy. For instance, these reminders are designed to prompt
providers based only on the date of test order and not the date of the result of the last test. If
the system had been configured as giving off a prompt based on both these dates, all 28
providers who unnecessarily ordered a PSA, Hba1c or a TSH would have received a prompt.
Future work is essential to better document whether the use of information technology can
reduce the enormous costs associated with redundant tests especially in the outpatient setting.
25;26
Our study had several limitations. Because of the study population (e.g. predominantly male
veterans) and the unique VA setting, our findings may not be generalizable outside the VA.
However, with increasing emphasis on electronic medical records the potential relevance of
these findings is significant. We also lack comparable data from non-electronic medical record
based systems and cannot comment on the effectiveness of automated notification compared
to these systems. Due to the lack of similar tracking and documentation capabilities, such an
evaluation study would be very difficult to carry out. Conversely, many factors including a
large sample size, multiple clinics, large number of providers (over 500 from different
specialties), rigorous methods to determine follow-up, explicit criteria for determination of
redundant tests, various types of abnormal lab alerts and an advanced integrated electronic
medical record used in VA facilities throughout the US, all add several unique strengths to our
study.
In conclusion, current systems of mandatory automated notification of abnormal lab results do
not guarantee timely follow-up on the abnormality in the outpatient setting. Additionally,
provider acknowledgment of receipt of the test result also does not automatically result in
timely follow-up. Multidisciplinary interventions involving human-computer interaction 3;21
and high-reliability tracking systems to monitor test result notification outcomes, such as
follow-up actions by providers on these tests, are needed to alleviate these safety concerns.
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Fig 1.
Study Flowchart and Outcomes
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Table 3
Criteria to determine alerts related to redundant laboratory tests and their respective frequencies (total n=202)
n (%)
HCV AB (Elisa) (n=131) *
 Known HCV ELISA positive and ongoing follow-up in Hepatitis C clinic ^ 32 (24.4)
 Known HCV ELISA positive and confirmed disease by either PCR+, viral load, or treatment genotype ^ 104 (79.4)
 Known HCV ELISA positive (but no viral load, PCR, or genotype) ^ 29 (22.1)
PSA (n=60) *
 Documentation of patient refusal for PSA work-up already present before PSA test was ordered 37 (61.7)
 Similar level of PSA that already had appropriate action taken within previous 4-weeks ^ 21 (35.0)
 Patient not a candidate for screening PSA testing 10 (16.7)
TSH (n=9)
 Test repeated within 4-weeks of last adjustment ^ 9 (100.0)
Hemoglobin A1C (n=2)
 Test repeated within 3-months of last adjustment ^ 2 (100.0)
*
Percentages add up to more than 100 because more than one criteria for redundancy may have been met in certain cases
^
Tests deemed redundant based on repetition
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